No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles
- 30 April 2009
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 91 (4), 1358-1361
- https://doi.org/10.1016/j.fertnstert.2008.03.077
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cyclesFertility and Sterility, 2007
- What is happening to the price of eggs?Fertility and Sterility, 2007
- ESHRE Task Force on Ethics and Law 12: Oocyte donation for non-reproductive purposesHuman Reproduction, 2007
- Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation ratesFertility and Sterility, 2006
- Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?Fertility and Sterility, 2006
- A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonistsHuman Reproduction, 2005
- GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized studyHuman Reproduction, 2005
- Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cyclesFertility and Sterility, 2003
- Rare occurrence of ovarian hyperstimulation syndrome in oocyte donorsInternational Journal of Gynecology & Obstetrics, 1996
- A case of severe ovarian hyperstimulation in a healthy oocyte donorFertility and Sterility, 1995